Citation: A. Markham et P. Benfield, PERGOLIDE - A REVIEW OF ITS PHARMACOLOGY AND THERAPEUTIC USE IN PARKINSONS-DISEASE. (VOL 7, PG 328, 1997), CNS DRUGS, 9(4), 1998, pp. 280-280
Citation: M. Dooley et A. Markham, PRAMIPEXOLE - A REVIEW OF ITS USE IN THE MANAGEMENT OF EARLY AND ADVANCED PARKINSONS-DISEASE, Drugs & aging, 12(6), 1998, pp. 495-514
Citation: Aj. Coukell et A. Markham, PAMIDRONATE - A REVIEW OF ITS USE IN THE MANAGEMENT OF OSTEOLYTIC BONE METASTASES, TUMOR-INDUCED HYPERCALCEMIA AND PAGETS-DISEASE OF BONE, Drugs & aging, 12(2), 1998, pp. 149-168
Citation: Rn. Brogden et A. Markham, MIBEFRADIL - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC EFFICACY IN THE MANAGEMENT OF HYPERTENSION ANDANGINA PECTORIS. (VOL 54, PG 774, 1997), Drugs, 55(4), 1998, pp. 517-517
Citation: Mi. Wilde et A. Markham, DANAPAROID - A REVIEW OF ITS PHARMACOLOGY AND CLINICAL USE IN THE MANAGEMENT OF HEPARIN-INDUCED THROMBOCYTOPENIA. (VOL 54, PG 903, 1997), Drugs, 55(4), 1998, pp. 517-517
Authors:
HUMPHREY GME
SQUIRE R
LANSDOWN M
MARKHAM A
MACLENNAN K
Citation: Gme. Humphrey et al., CYTOGENETICS AND THE SURGEON - AN INVALUABLE TOOL IN DIAGNOSIS, PROGNOSIS AND COUNSELING OF PATIENTS WITH SOLID TUMORS, British Journal of Surgery, 85(6), 1998, pp. 725-734
Citation: A. Markham et P. Benfield, PERGOLIDE - A REVIEW OF ITS PHARMACOLOGY AND THERAPEUTIC USE IN PARKINSONS-DISEASE, CNS DRUGS, 7(4), 1997, pp. 328-340
Citation: Hd. Langtry et A. Markham, LISINOPRIL - A REVIEW OF ITS PHARMACOLOGY AND CLINICAL EFFICACY IN ELDERLY PATIENTS, Drugs & aging, 10(2), 1997, pp. 131-166
Citation: Jc. Gillis et A. Markham, IRBESARTAN - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES AND THERAPEUTIC USE IN THE MANAGEMENT OF HYPERTENSION, Drugs, 54(6), 1997, pp. 885-902
Citation: Mi. Wilde et A. Markham, DANAPAROID - A REVIEW OF ITS PHARMACOLOGY AND CLINICAL USE IN THE MANAGEMENT OF HEPARIN-INDUCED THROMBOCYTOPENIA, Drugs, 54(6), 1997, pp. 903-924
Citation: Rn. Brogden et A. Markham, MIBEFRADIL - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC EFFICACY IN THE MANAGEMENT OF HYPERTENSION ANDANGINA-PECTORIS, Drugs, 54(5), 1997, pp. 774-793
Citation: Rn. Brogden et A. Markham, FENOLDOPAM - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES AND INTRAVENOUS CLINICAL POTENTIAL IN THE MANAGEMENT OF HYPERTENSIVE URGENCIES AND EMERGENCIES, Drugs, 54(4), 1997, pp. 634-650
Citation: A. Markham et Kl. Goa, VALSARTAN - A REVIEW OF ITS PHARMACOLOGY AND THERAPEUTIC USE IN ESSENTIAL-HYPERTENSION, Drugs, 54(2), 1997, pp. 299-311
Citation: Rh. Foster et al., IBUTILIDE - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND CLINICAL POTENTIAL IN THE ACUTE MANAGEMENT OF ATRIAL-FLUTTER AND FIBRILLATION, Drugs, 54(2), 1997, pp. 312-330
Citation: Jc. Adkins et al., FLUDARABINE - AN UPDATE OF ITS PHARMACOLOGY AND USE IN THE TREATMENT OF HEMATOLOGICAL MALIGNANCIES, Drugs, 53(6), 1997, pp. 1005-1037
Citation: Kl. Goa et al., SPARFLOXACIN - A REVIEW OF ITS ANTIBACTERIAL ACTIVITY, PHARMACOKINETIC PROPERTIES, CLINICAL EFFICACY AND TOLERABILITY IN LOWER RESPIRATORY-TRACT INFECTIONS, Drugs, 53(4), 1997, pp. 700-725